ArticleThe Lancet regional health. Europe2024

Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: a population-based observational study.

Claudia Weiß et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.